Physician profile
Denisea Mount
NPI 1902423726
$4,913.13
in general payments reported to CMS, 2019-2025
26 companies · $2,280 in 2025
The $2,280 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $348 · 2023: $825 · 2024: $1,179 · 2025: $2,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,284.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $1,280.93 | 2021-2025 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $1,129.01 | 2021-2025 | Airsupra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $596.70 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Mylan Specialty L.P. | $497.58 | 2021-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $339.75 | 2021-2025 | Glassia |
| Genzyme Corporation | $197.83 | 2024-2025 | |
| Novo Nordisk INC | $164.92 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Mallinckrodt Hospital Products INC. | $95.76 | 2025 | Acthar |
| Insmed, INC. | $73.13 | 2024-2025 | Arikayce, Brinsupri |
| Lilly USA, LLC | $70.66 | 2025 | Zepbound, Mounjaro |
| Viatris Specialty LLC | $66.89 | 2025 | Yupelri |
| Verona Pharma, INC. | $58.67 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $52.35 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Teva Pharmaceuticals USA, INC. | $44.35 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.94 | 2021-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $29.93 | 2024 | Sunosi |
| Medtronic, INC. | $26.63 | 2025 | Venaseal |
| Actelion Pharmaceuticals US, INC. | $20.58 | 2025 | Opsumit, Uptravi |
| Abbvie INC. | $20.00 | 2024 | |
| Paratek Pharmaceuticals, INC. | $17.69 | 2021 | |
| Philips North America LLC | $17.28 | 2022 | |
| Exact Sciences Corporation | $17.27 | 2025 | Cologuard Collection Kit |
| Baxter Healthcare | $17.09 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.00 | 2025 | Rexulti |
| Evoke Pharma, INC. | $14.52 | 2025 | |
| Biogen, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denisea Mount listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.